Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors
Study Details
Study Description
Brief Summary
This clinical trial studies dietary and exercise interventions in preventing cardiovascular disease in younger survivors of childhood cancer. Eating a healthy diet and exercising regularly may reduce the risk of cardiovascular disease in younger survivors of childhood cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Participants receive personalized exercise plan and prescription tailored to individual needs and current level of activity and fitness, and they also receive 2 one-hour individual exercise training sessions consisting of 20-30 minutes cardiovascular activity and strength training. Participants receive nutritional education consisting of energy balance, appropriate portion sizes, calorie count, and basic nutrition skills such as label reading every 2 weeks for 12 weeks.
After completion of study treatment, patients are followed for up to 6 months.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Chemotherapy |
Behavioral: Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Chemotherapy
Participants will be taught by a registered dietician about energy balance and how body weight relates to energy intake and expenditure, although specific calorie prescriptions will not be given. An exercise physiologist will create a personalized exercise plan and prescription which is tailored to his / her needs and current level of activity and fitness
|
Outcome Measures
Primary Outcome Measures
- Feasibility determined by average attendance and retention [At 3 months]
Acceptability will be determined by responses on feedback measures and qualitative analysis of exit interviews.
Secondary Outcome Measures
- Feasibility determined by average attendance and retention from the blood pressure at enrollment [At 6 months]
Will be assessed via paired T test.
- Acceptability level at time of enrollment [At 6 months]
Acceptability will be determined by responses on feedback measures and qualitative analysis of exit interviews.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis of pediatric cancer
-
Patients 3 months to 1 year after completion of therapy
Exclusion Criteria:
-
Patients who are already on antihypertensive or insulin or cholesterol lowering medication
-
Patients who have not been evaluated for exercise tolerance and cleared by their physician for participation
-
Inability to understand program instructions due to language barrier or mental disability
-
Unable to participate in the outlined exercise program due to a physical disability
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Virginia Commonwealth University
Investigators
- Principal Investigator: Marieka A Helou, MD, Massey Cancer Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MCC-14062
- HM14062